|
1
|
Braun MM, Overbeek-Wager EA and Grumbo RJ:
Diagnosis and management of endometrial cancer. Am Fam Physician.
93:468–474. 2016.PubMed/NCBI
|
|
2
|
McAlpine JN, Temkin SM and Mackay HJ:
Endometrial cancer: Not your grandmother's cancer. Cancer.
122:2787–2798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsikouras P, Bouchlariotou S, Vrachnis N,
Dafopoulos A, Galazios G, Csorba R and von Tempelhoff GF:
Endometrial cancer: Molecular and therapeutic aspects. Eur J Obstet
Gynecol Reprod Biol. 169:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Colombo N, Creutzberg C, Amant F, Bosse T,
González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza
MR, et al: ESMO-ESGO-ESTRO consensus conference on endometrial
cancer: Diagnosis, treatment and follow-up. Ann Oncol. 27:16–41.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hutt S, Tailor A, Ellis P, Michael A,
Butler-Manuel S and Chatterjee J: The role of biomarkers in
endometrial cancer and hyperplasia: A literature review. Acta
Oncol. 58:342–352. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stope MB, Koensgen D, Weimer J, Paditz M,
Burchardt M, Bauerschlag D and Mustea A: The future therapy of
endometrial cancer: microRNA's functionality, capability, and
putative clinical application. Arch Gynecol Obstet. 294:889–895.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rižner TL: Discovery of biomarkers for
endometrial cancer: Current status and prospects. Expert Rev Mol
Diagn. 16:1315–1336. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li HL, Sun JJ, Ma H, Liu SJ, Li N, Guo SJ,
Shi Y, Xu YY, Qi ZY, Wang YQ, et al: MicroRNA-23a inhibits
endometrial cancer cell development by targeting SIX1. Oncol Lett.
18:3792–3802. 2019.PubMed/NCBI
|
|
13
|
Kong J, He X, Wang Y and Li J: Effect of
microRNA-29b on proliferation, migration, and invasion of
endometrial cancer cells. J Int Med Res. 47:3803–3817. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Zhang L, Jiang W, Zhang R, Zhang
B, Silayiding A and Duan X: MicroRNA-135a promotes proliferation,
migration, invasion and induces chemoresistance of endometrial
cancer cells. Eur J Obstet Gynecol Reprod Biol X. 5:1001032020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fuziwara CS and Kimura ET: Insights into
Regulation of the miR-17-92 Cluster of miRNAs in Cancer. Front Med
(Lausanne). 2:642015.PubMed/NCBI
|
|
16
|
Agrawal S, Tapmeier T, Rahmioglu N,
Kirtley S, Zondervan K and Becker C: The miRNA Mirage: How close
are we to finding a non-invasive diagnostic biomarker in
endometriosis? A systematic review. Int J Mol Sci. 19:5992018.
View Article : Google Scholar
|
|
17
|
Ramón LA, Braza-Boïls A, Gilabert J,
Chirivella M, España F, Estellés A and Gilabert-Estellés J:
MicroRNAs related to angiogenesis are dysregulated in endometrioid
endometrial cancer. Hum Reprod. 27:3036–3045. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schwartz DM, Bonelli M, Gadina M and
O'Shea JJ: Type I/II cytokines, JAKs, and new strategies for
treating autoimmune diseases. Nat Rev Rheumatol. 12:25–36. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kleppe M, Kwak M, Koppikar P, Riester M,
Keller M, Bastian L, Hricik T, Bhagwat N, McKenney AS, Papalexi E,
et al: JAK-STAT pathway activation in malignant and nonmalignant
cells contributes to MPN pathogenesis and therapeutic response.
Cancer Discov. 5:316–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitchell TJ and John S: Signal transducer
and activator of transcription (STAT) signalling and T-cell
lymphomas. Immunology. 114:301–312. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L, Huang W, Ren C, Zhao M, Jiang X,
Fang X and Xia X: Analysis of serum microRNA profile by solexa
sequencing in women with endometriosis. Reprod Sci. 23:1359–1370.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia SZ, Yang Y, Lang J, Sun P and Leng J:
Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women
with endometriosis. Hum Reprod. 28:322–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin SC, Wang CC, Wu MH, Yang SH, Li YH and
Tsai SJ: Hypoxia-induced microRNA-20a expression increases ERK
phosphorylation and angiogenic gene expression in endometriotic
stromal cells. J Clin Endocrinol Metab. 97:E1515–E1523. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eismann J, Hirschfeld M, Erbes T, Rücker
G, Jäger M, Ritter A, Weiss D, Gitsch G and Mayer S: Hypoxia- and
acidosis-driven aberrations of secreted microRNAs in endometrial
cancer in vitro. Oncol Rep. 38:993–1004. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Zheng L, Ding Y, Li Q, Wang R,
Liu T, Sun Q, Yang H, Peng S, Wang W and Chen L: miR-20a induces
cell radioresistance by activating the PTEN/PI3K/Akt signaling
pathway in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys.
92:1132–1140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang D, Bian G, Pan Y, Han X, Sun Y, Wang
Y, Shen G, Cheng M, Fang X and Hu S: miR-20a-5p promotes
radio-resistance by targeting Rab27B in nasopharyngeal cancer
cells. Cancer Cell Int. 17:322017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao W, Geng D, Li S, Chen Z and Sun M:
LncRNA HOTAIR influences cell growth, migration, invasion, and
apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer
Med. 7:842–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng D, Zhao S, Tang H, Zhang D, Sun H,
Yu F, Jiang W, Yue B, Wang J, Zhang M, et al: MicroRNA-20a-5p
promotes colorectal cancer invasion and metastasis by
downregulating Smad4. Oncotarget. 7:45199–45213. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang Y and Yang N: MicroRNA-20a-5p
inhibits epithelial to mesenchymal transition and invasion of
endometrial cancer cells by targeting STAT3. Int J Clin Exp Pathol.
11:5715–5724. 2018.PubMed/NCBI
|
|
31
|
Chen LT and Jiang CY: MicroRNA expression
profiles identify biomarker for differentiating the embolic stroke
from thrombotic stroke. Biomed Res Int. 2018:45141782018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Roskoski R Jr: Janus kinase (JAK)
inhibitors in the treatment of inflammatory and neoplastic
diseases. Pharmacol Res. 111:784–803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sexl V, Kovacic B, Piekorz R, Moriggl R,
Stoiber D, Hoffmeyer A, Liebminger R, Kudlacek O, Weisz E,
Rothammer K and Ihle JN: Jak1 deficiency leads to enhanced
Abelson-induced B-cell tumor formation. Blood. 101:4937–4943. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yeh YT, Ou-Yang F, Chen IF, Yang SF, Su
JH, Hou MF and Yuan SS: Altered p-JAK1 expression is associated
with estrogen receptor status in breast infiltrating ductal
carcinoma. Oncol Rep. 17:35–39. 2007.PubMed/NCBI
|
|
35
|
van der Zee M, Sacchetti A, Cansoy M,
Joosten R, Teeuwssen M, Heijmans-Antonissen C, Ewing-Graham PC,
Burger CW, Blok LJ and Fodde R: IL6/JAK1/STAT3 signaling blockade
in endometrial cancer affects the ALDHhi/CD126+
stem-like component and reduces tumor burden. Cancer Res.
75:3608–3622. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ren Y, Zhang Y, Liu RZ, Fenstermacher DA,
Wright KL, Teer JK and Wu J: JAK1 truncating mutations in
gynecologic cancer define new role of cancer-associated protein
tyrosine kinase aberrations. Sci Rep. 3:30422013. View Article : Google Scholar : PubMed/NCBI
|
